Steward Partners Investment Advisory, LLC Avidity Biosciences, Inc. Transaction History
Steward Partners Investment Advisory, LLC
- $9.37 Billion
- Q2 2024
A detailed history of Steward Partners Investment Advisory, LLC transactions in Avidity Biosciences, Inc. stock. As of the latest transaction made, Steward Partners Investment Advisory, LLC holds 103,200 shares of RNA stock, worth $4.88 Million. This represents 0.04% of its overall portfolio holdings.
Number of Shares
103,200
Previous 100,500
2.69%
Holding current value
$4.88 Million
Previous $2.56 Million
64.39%
% of portfolio
0.04%
Previous 0.03%
Shares
7 transactions
Others Institutions Holding RNA
# of Institutions
219Shares Held
95.9MCall Options Held
171KPut Options Held
196K-
Price T Rowe Associates Inc Baltimore, MD10.9MShares$516 Million0.05% of portfolio
-
Rtw Investments, LP New York, NY8.81MShares$416 Million6.01% of portfolio
-
Black Rock Inc. New York, NY8.62MShares$407 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY6.51MShares$307 Million3.63% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.94MShares$281 Million0.0% of portfolio
About Avidity Biosciences, Inc.
- Ticker RNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,127,000
- Market Cap $2.46B
- Description
- Avidity Biosciences, Inc., a biopharmaceutical company, engages in the development of oligonucleotide-based therapies. It develops antibody oligonucleotide conjugates (AOC) that are designed to treat a range of serious diseases. The company's lead product candidate AOC 1001 is used for the treatment of myotonic dystrophy type 1, a rare monogenic...